TCEAL2 anticorps (N-Term)
Aperçu rapide pour TCEAL2 anticorps (N-Term) (ABIN928439)
Antigène
Voir toutes TCEAL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- TCEAL2 antibody was raised in rabbit using the N terminal of TCEAL2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
TCEAL2 Blocking Peptide, (ABIN5616527), is also available for use as a blocking control in assays to test for specificity of this TCEAL2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- TCEAL2 (Transcription Elongation Factor A (SII)-Like 2 (TCEAL2))
-
Autre désignation
- TCEAL2
-
Sujet
- TCEAL2 is a member of the transcription elongation factor A (SII)-like (TCEAL) gene family. Members of this family contain TFA domains and may function as nuclear phosphoproteins that modulate transcription in a promoter context-dependent manner. Synonyms: Polyclonal TCEAL2 antibody, Anti-TCEAL2 antibody, transcription elongation factor A, SII-like 2 antibody, MY0876G05 antibody, my048 antibody.
Antigène
-